Posts

Showing posts from November, 2024

mRNA Synthesis Raw Materials Market Forecast and Growth Opportunities Ahead

  The global mRNA synthesis raw materials market size is projected to reach   USD 1.99 billion by 2030 , according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.85% from 2024 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.   Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets ...

Synthetic Biology Market: A Comprehensive Overview of Applications and Technologies

  The global synthetic biology market size is expected to reach   USD 42.06 billion by 2030 , registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.   Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the N...

Understanding the Europe, CIS & Africa Spatial Transcriptomics Market: A Deep Dive into Applications and Technologies

  The Europe, CIS & Africa Spatial Transcriptomics Market   The spatial transcriptomics market in Europe, CIS, and Africa is experiencing significant growth. In 2023, it was valued at  USD 93.9 million , and it's projected to expand at a Compound Annual Growth Rate (CAGR) of 15.57% from 2024 to 2030.  Key Drivers of Market Growth:   Several factors are contributing to this robust growth:  Advancements in Spatial Omics: The emergence of spatial omics analysis, particularly in cancer research, is revolutionizing our understanding of biological processes. The development of fourth-generation sequencing (in-situ sequencing) is further propelling the field by enabling direct sequencing of RNA and DNA within tissues. Increased Research Funding and Collaboration: Significant investments and collaborative efforts in spatial biology research are fueling innovation and accelerating the development of new technologies and applications. Rising Cancer Prevalence: Th...